What is Chronic Pain
Chronic pain becomes chronic when it persists longer than 6 months and is resistant to medical management. Millions of Americans are chronic pain patients and some exper...
Join Now
|
Good Pills, Bad Pills, Vioxx is back!
|
Watch this |
| View More Posts Ignore |
February 22, 2005
"Good Pills, Bad Pills: Dr. Sidney Wolfe Condemns FDA Advisors For Backing the Sale of Vioxx, Celebrex and Bextra Despite Known Dangers The FDA panel proposed that the drugs be sold with an FDA “black box” warning. Vioxx is now expected to return to the market even though nearly half the FDA panel voted against it being sold. Its manufacturer Merck voluntarily withdrew the painkiller drug in the fall. Studies have show as many as 55,000 people may have died from taking the drug. [includes rush transcript] >Share delicio.us digg facebook newsvine reddit slashdot stumbleupon Email to a friend Help Printer-friendly version Purchase DVD/CD LISTEN WATCH Real Video Stream Real Audio Stream MP3 Download More… A Food and Drug Administration advisory panel has voted to allow doctors to keep prescribing the popular painkillers Vioxx, Celebrex and Bextra even though the panel overwhelmingly agreed that the drugs significantly increase the risk of cardiovascular problems in patients. The panel proposed that the drugs be sold with an FDA “black box” warning. Vioxx is now expected to return to the market even though nearly half the FDA panel voted against it being sold. Its manufacturer Merck voluntarily withdrew the painkiller drug in the fall. The FDA panel decided whether a drug should be allowed to be sold on a straight majority vote. The vote for Vioxx was 17 to 15. For Bextra, 17 panelists vote for the drug and 13 voted to ban it. The panel nearly unanimously recommended Celebrex remaining available. Last year FDA whistleblower Dr. David Graham publicly estimated that 139,000 Americans who took Vioxx suffered serious side effects. Of these users he estimated that the drug killed between 26,000 and 55,000 people. The FDA is not required to follow the recommendations of the panel, but generally does so. Minutes after the announcement, Merck stock shot up nearly 12 percent on the New York Stock Exchange. Pfizer shares rose by 5.6 percent. We are joined in Washington by Dr. Sidney Wolfe, director of Public Citizen’s Health Research Group. Dr. Sidney Wolfe, Director of Public Citizen’s Health Research Group." http://www.democracynow.org/2005/2... Posted on 02/12/09, 11:02 am |
| 2 Replies | Add Your Reply |
| View More Posts Ignore |
Excuse my unedited post please, computer problems. If interested please read or listen to the entire Amy Goodman interview.
Tami Pain Relief Network 
|
|
|
|
||
| View More Posts Ignore |
I know the article is dated but
I found this very interesting in light of this FDA question and answer page on rofecoxib dated Sept 30, 2004. And were at the mercy of these people, the government! http://www.fda.gov/CDER/DRUG/infop... Tami
|
|
|
|
||
| Add Your Reply |
